Department of Medicine, Imperial College London, London, UK.
Pediatr Res. 2011 Sep;70(3):287-91. doi: 10.1203/PDR.0b013e318225f9b1.
Maternal overweight and obesity are associated with adverse offspring outcome in later life. The causal biological effectors are uncertain. Postulating that initiating events may be alterations to infant body composition established in utero, we tested the hypothesis that neonatal adipose tissue (AT) content and distribution and liver lipid are influenced by maternal BMI. We studied 105 healthy mother-neonate pairs. We assessed infant AT compartments by whole body MR imaging and intrahepatocellular lipid content by H MR spectroscopy. Maternal BMI ranged from 16.7 to 36.0. With each unit increase in maternal BMI, having adjusted for infant sex and weight, there was an increase in infant total (8 mL; 95% CI, 0.09-14.0; p = 0.03), abdominal (2 mL; 95% CI, 0.7-4.0; p = 0.005), and nonabdominal (5 mL; 95% CI, 0.09-11.0; p = 0.054) AT, and having adjusted for infant sex and postnatal age, an increase of 8.6% (95% CI, 1.1-16.8; p = 0.03) in intrahepatocellular lipid. Infant abdominal AT and liver lipid increase with increasing maternal BMI across the normal range. These effects may be the initiating determinants of a life-long trajectory leading to adverse metabolic health.
母亲超重和肥胖与后代生命后期的不良结局有关。因果生物学效应尚不确定。假设起始事件可能是胎儿期婴儿身体成分的改变,我们检验了以下假设,即新生儿脂肪组织 (AT) 含量和分布以及肝脂质受母亲 BMI 的影响。我们研究了 105 对健康的母婴对。我们通过全身 MRI 评估婴儿的 AT 隔室,通过 H 磁共振波谱评估肝细胞内脂质含量。母亲 BMI 范围从 16.7 到 36.0。与母亲 BMI 每增加一个单位,在调整婴儿性别和体重后,婴儿的总脂肪 (8 毫升; 95%CI,0.09-14.0; p = 0.03)、腹部 (2 毫升; 95%CI,0.7-4.0; p = 0.005) 和非腹部 (5 毫升; 95%CI,0.09-11.0; p = 0.054) 脂肪增加,调整婴儿性别和产后年龄后,肝细胞内脂质增加 8.6% (95%CI,1.1-16.8; p = 0.03)。随着母亲 BMI 正常范围内的增加,婴儿腹部 AT 和肝脂质增加。这些影响可能是导致不良代谢健康的终身轨迹的起始决定因素。